Search research articles
Contact Us
Filters
Showing results (111-120 of 121) with videos related to
Page
of 13
Sort By:
Nature Communications
|
July 10, 2024
Germ granule compartments coordinate specialized small RNA production
Xiangyang Chen, Ke Wang, Farees Ud Din Mufti, et al.
Critical Care (London, England)
|
December 19, 2020
Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study
Yiming Li, Qinghe Meng, Xin Rao, et al.
Cardiovascular Diabetology
|
December 26, 2022
'Stress hyperglycemia ratio and in-hospital prognosis in non-surgical patients with heart failure and type 2 diabetes
Yiling Zhou, Li Liu, Hongmei Huang, et al.
Aging
|
May 10, 2021
Plasma hemoglobin and the risk of death in HIV/AIDS patients treated with antiretroviral therapy
Dayong Wang, Xiangqing Hou, Xianghua Yu, et al.
Nature Structural & Molecular Biology
|
May 2, 2025
piRNA gene density and SUMOylation organize piRNA transcriptional condensate formation
Chengming Zhu, Xiaoyue Si, Xinhao Hou, et al.
Journal of Clinical Medicine
|
November 26, 2022
Glycated Haemoglobin A1c Variability Score Elicits Kidney Function Decline in Chinese People Living with Type 2 Diabetes
Yiling Zhou, Hongmei Huang, Xueqin Yan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 18, 2023
Biochemical and structural characterization of a sphingomonad diarylpropane lyase for cofactorless deformylation
Eugene Kuatsjah, Michael Zahn, Xiangyang Chen, et al.
Journal of Medicinal Chemistry
|
August 3, 2010
Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy
Marvin J Meyers, Graciela B Arhancet, Susan L Hockerman, et al.
Journal of Medicinal Chemistry
|
April 18, 2014
Identification of (R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic acid, a highly potent and selective nonsteroidal mineralocorticoid receptor antagonist
Agustin Casimiro-Garcia, David W Piotrowski, Catherine Ambler, et al.
BMJ (Clinical Research Ed.)
|
April 6, 2023
Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
Qingyang Shi, Kailei Nong, Per Olav Vandvik, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 121) with videos related to
Sort By:
Page
of 13
Nature Communications
|
July 10, 2024
Germ granule compartments coordinate specialized small RNA production
Xiangyang Chen, Ke Wang, Farees Ud Din Mufti, et al.
Critical Care (London, England)
|
December 19, 2020
Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study
Yiming Li, Qinghe Meng, Xin Rao, et al.
Cardiovascular Diabetology
|
December 26, 2022
'Stress hyperglycemia ratio and in-hospital prognosis in non-surgical patients with heart failure and type 2 diabetes
Yiling Zhou, Li Liu, Hongmei Huang, et al.
Aging
|
May 10, 2021
Plasma hemoglobin and the risk of death in HIV/AIDS patients treated with antiretroviral therapy
Dayong Wang, Xiangqing Hou, Xianghua Yu, et al.
Nature Structural & Molecular Biology
|
May 2, 2025
piRNA gene density and SUMOylation organize piRNA transcriptional condensate formation
Chengming Zhu, Xiaoyue Si, Xinhao Hou, et al.
Journal of Clinical Medicine
|
November 26, 2022
Glycated Haemoglobin A1c Variability Score Elicits Kidney Function Decline in Chinese People Living with Type 2 Diabetes
Yiling Zhou, Hongmei Huang, Xueqin Yan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 18, 2023
Biochemical and structural characterization of a sphingomonad diarylpropane lyase for cofactorless deformylation
Eugene Kuatsjah, Michael Zahn, Xiangyang Chen, et al.
Journal of Medicinal Chemistry
|
August 3, 2010
Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy
Marvin J Meyers, Graciela B Arhancet, Susan L Hockerman, et al.
Journal of Medicinal Chemistry
|
April 18, 2014
Identification of (R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic acid, a highly potent and selective nonsteroidal mineralocorticoid receptor antagonist
Agustin Casimiro-Garcia, David W Piotrowski, Catherine Ambler, et al.
BMJ (Clinical Research Ed.)
|
April 6, 2023
Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
Qingyang Shi, Kailei Nong, Per Olav Vandvik, et al.
Page
of 13